Business Context and Reporting Period
Company: Oramed Pharmaceuticals Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: August 19, 2009
Event Date: August 18, 2009
Context: The filing discloses a Regulation FD event regarding the company's Chief Scientific Officer, Dr. Miriam Kidron, being selected to lecture at the 2009 British Pharmaceutical Conference in Manchester, England, scheduled for September 9, 2009.
Key Financial Metrics
This filing is a current report regarding a corporate event and does not contain financial statements. The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
No material financial changes or operational updates were reported in this filing. The sole material event is the announcement of Dr. Kidron's speaking engagement.
Guidance, Outlook, and Risks
Management Commentary: The filing incorporates by reference a press release (Exhibit 99.1) announcing the lecture. No specific financial guidance, outlook, or risk factors were detailed within the body of this 8-K report.
Investor Verification Checklist
- Verify the content of the attached press release (Exhibit 99.1) for details on the lecture topic.
- Confirm the date and location of the 2009 British Pharmaceutical Conference.
- Note that this filing contains no financial data; refer to the most recent 10-K or 10-Q for financial status.